Author:
Robinson Karen A,Odelola Olaide A,Saldanha Ian J
Reference53 articles.
1. A phase IV study of the safety of Synagis® (Palivizumab) for prophylaxis of respiratory syncytial virus disease in children with cystic fibrosis;Cohen,2005
2. A phase IV study of the safety of Synagis® (Palivizumab) for prophylaxis of respiratory syncytial virus disease in children with cystic fibrosis [abstract];Cohen,2005
3. Policy statement modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections;Pediatrics,2009
4. Role of respiratory syncytial virus in early hospitalization for respiratory distress of young infants with cystic fibrosis;Abman;Journal of Pediatrics,1988
5. Severe viral respiratory infections in infants with cystic fibrosis;Armstrong;Pediatric Pulmonology,1998
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献